JAI, Oxford
Imperial College of Science and Technology, Department of Physics, London
UMAN, Manchester
STFC/DL/ASTeC, Daresbury, Warrington, Cheshire
STFC/DL, Daresbury, Warrington, Cheshire
STFC/RAL, Chilton, Didcot, Oxon
Brunel University, Middlesex
GIROB, Oxford
Fermilab, Batavia
Gray Institute for Radiation Oncology and Biology, Oxford
STFC/RAL/ASTeC, Chilton, Didcot, Oxon
Cockcroft Institute, Lancaster University, Lancaster
Funding: EPSRC EP/E032869/1
The PAMELA (Particle Accelerator for MEdicaL Applications) project is to design an accelerator for proton and light ion therapy using non-scaling Fixed Field Alternating Gradient (FFAG) accelerators, as part of the CONFORM project, which is also constructing the EMMA electron model of a non-scaling FFAG at Daresbury. This paper presents an overview of the PAMELA design, and a discussion of the design goals and the principles used to arrive at a preliminary specification of the accelerator.
STFC/RAL/ISIS, Chilton, Didcot, Oxon
ISIS is the spallation neutron source at the Rutherford Appleton Laboratory in the UK. Operation centres on a 50 Hz proton synchrotron, which accelerates ~3·1013 ppp from 70 to 800 MeV, corresponding to beam powers of 0.2 MW. Beam loss imposes limits on operational intensity, and a main contributing mechanism is the action of half integer resonance under high space charge. The same loss mechanism is also a potential problem in ISIS upgrade scenarios involving either higher energy injection into the existing ring, or the addition of a new 3 GeV, high intensity RCS. Progress on particle in cell simulation studies investigating the effects of the driven coherent envelope motion, the associated parametric halo, along with implications of momentum spread, dispersion and longitudinal motion, is reported. Where possible, comparisons are made with relevant theoretical models. Closely related benchmarking work, experimental studies and plans are also summarised.